Cargando…

Long-Term Therapy Outcomes When Treating Chronic Kidney Disease Patients with Paricalcitol in German and Austrian Clinical Practice (TOP Study)

Paricalcitol is approved for prevention and therapy of secondary hyperparathyroidism (sHPT) in patients with chronic kidney disease (CKD), with only short-term data in clinical routine settings. A 12-month observational study was conducted in Germany and Austria (90 centers, 761 patients) from 2008...

Descripción completa

Detalles Bibliográficos
Autores principales:	Obermüller, Nicholas, Rosenkranz, Alexander R., Müller, Hans-Walter, Hidde, Dennis, Veres, András, Decker-Burgard, Sabine, Weisz, Isolde, Geiger, Helmut
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2017
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5666739/ https://www.ncbi.nlm.nih.gov/pubmed/28956807 http://dx.doi.org/10.3390/ijms18102057

Ejemplares similares

Etelcalcetide and Paricalcitol in Chronic Kidney Disease: When the Target Is Inflammation
por: D’Marco, Luis, et al.
Publicado: (2022)

More Evils of German and Austrian Clinics
Publicado: (1919)

The 2013 Austrian-Swiss-German Traveling Fellowship Tour
por: Renkawitz, Tobias, et al.
Publicado: (2014)

Abstracts of the 10th German/Austrian AIDS Conference
Publicado: (2021)

Antiapoptotic Effect of Paricalcitol in Gentamicin-induced Kidney Injury
por: Suh, Sang Heon, et al.
Publicado: (2013)

Paricalcitol reduces oxidative stress and inflammation in hemodialysis patients
por: Izquierdo, María Jesús, et al.
Publicado: (2012)

First German-Austrian case-mix comparison with real life data
por: Wilke, Michael, et al.
Publicado: (2008)

Phonotactic information in the temporal organization of Standard Austrian German and the Viennese dialect
por: Moosmüller, Sylvia, et al.
Publicado: (2014)

Development of the German version of the patient safety climate inventory to the Austrian context
por: Draganović, Šehad, et al.
Publicado: (2022)

Long-Term Vaptan Treatment of Idiopathic SIADH in an Octogenarian
por: Büttner, Stefan, et al.
Publicado: (2017)

Oral Paricalcitol for the Treatment of Secondary Hyperparathyroidism in Chronic Kidney Disease
por: Cheng, Steven, et al.
Publicado: (2006)

Protective Effects of Paricalcitol on Peritoneal Remodeling during Peritoneal Dialysis
por: Stavenuiter, Andrea W. D., et al.
Publicado: (2015)

Role of Paricalcitol in Modulating the Immune Response in Patients with Renal Disease
por: Lucisano, Silvia, et al.
Publicado: (2015)

Paricalcitol Versus Calcifediol for Treating Hyperparathyroidism in Kidney Transplant Recipients
por: Cruzado, Josep M., et al.
Publicado: (2017)

Mortality in Hemodialysis Patients with COVID-19, the Effect of Paricalcitol or Calcimimetics
por: Arenas Jimenez, María Dolores, et al.
Publicado: (2021)

Effects of Paricalcitol on Body Composition in Vitamin D-Deficient Rats
por: Koohpeyma, Farhad, et al.
Publicado: (2021)

Paricalcitol in hemodialysis patients with secondary hyperparathyroidism and its potential benefits
por: Chen, Xiu, et al.
Publicado: (2021)

The Orthopaedic forum 2011 Austrian-Swiss-German traveling fellowship tour summary
por: Jäger, Marcus, et al.
Publicado: (2011)

It is not ‘business as usual’ for orthopaedic surgeons in May 2020– the Austrian-German-Swiss experience
por: Liebensteiner, M. C., et al.
Publicado: (2020)

Comparison of the Pharmacological Effects of Paricalcitol and Doxercalciferol on the Factors Involved in Mineral Homeostasis
por: Wu-Wong, J. Ruth, et al.
Publicado: (2010)

Cardiac and Renal Effects of Atrasentan in Combination with Enalapril and Paricalcitol in Uremic Rats
por: Ritter, Cynthia, et al.
Publicado: (2014)

Asymmetric Dimethylarginine (ADMA) Levels Are Lower in Hemodialysis Patients Treated With Paricalcitol
por: Oliva-Damaso, Elena, et al.
Publicado: (2016)

Efficacy and safety of paricalcitol in patients undergoing hemodialysis: a meta-analysis
por: Liu, Yang, et al.
Publicado: (2019)

The Value of Tumour Markers in the Detection of Relapse—Lessons Learned from the Swiss Austrian German Testicular Cancer Cohort Study
por: Fischer, Stefanie, et al.
Publicado: (2023)

Diabetes management in Wolcott-Rallison syndrome: analysis from the German/Austrian DPV database
por: Welters, Alena, et al.
Publicado: (2020)

Hydrocortisone dosing in children with classic congenital adrenal hyperplasia: results of the German/Austrian registry
por: Hoyer-Kuhn, Heike, et al.
Publicado: (2021)

German-Austrian consensus on operative treatment of Charcot neuroarthropathy: a Perspective by the Charcot task force of the German Association for Foot Surgery
por: Koller, Armin, et al.
Publicado: (2011)

The Effect of Paricalcitol on Vascular Calcification and Cardiovascular Disease in Uremia: Beyond PTH Control
por: Cozzolino, Mario, et al.
Publicado: (2011)

Differential expression and regulation of Klotho by paricalcitol in the kidney, parathyroid and aorta of uremic rats
por: Ritter, Cynthia S., et al.
Publicado: (2015)

Efficacy and safety of paricalcitol in children with stages 3 to 5 chronic kidney disease
por: Webb, Nicholas J. A., et al.
Publicado: (2017)

Neuroprotective effect of paricalcitol in a rat model of transient global cerebral ischemia
por: Kim, Sung Wook, et al.
Publicado: (2020)

Paricalcitol Attenuates Contrast-Induced Acute Kidney Injury by Regulating Mitophagy and Senescence
por: Bae, Eunjin, et al.
Publicado: (2020)

Preclinical Therapy with Vitamin D3 in Experimental Encephalomyelitis: Efficacy and Comparison with Paricalcitol
por: Mimura, Luiza Ayumi Nishiyama, et al.
Publicado: (2021)

Effects of paricalcitol on calcium and phosphate metabolism and markers of bone health in patients with diabetic nephropathy: results of the VITAL study
por: Coyne, Daniel W., et al.
Publicado: (2013)

Adherence to fast track measures in colorectal surgery—a survey among German and Austrian surgeons
por: Willis, Maria A., et al.
Publicado: (2023)

Mitochondrial Haplogroup T Is Associated with Obesity in Austrian Juveniles and Adults
por: Ebner, Sabine, et al.
Publicado: (2015)

Do Austrian “INTEGRI (integrated care) projects” comply with international definitions and concepts?
por: Geiger, Isabel, et al.
Publicado: (2017)

The influence of selective vitamin D receptor activator paricalcitol on cardiovascular system and cardiorenal protection
por: Duplancic, Darko, et al.
Publicado: (2013)

Successful Treatment of Severe Atopic Dermatitis with Calcitriol and Paricalcitol in an 8-Year-Old Girl
por: Bothou, Christina, et al.
Publicado: (2018)

Paricalcitol vs. cinacalcet for secondary hyperparathyroidism in chronic kidney disease: A meta-analysis
por: Xu, Wei, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_6vmpjn47gel26rnhsg053p9913